Updated 06:11 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,883.00 +0.78% CL 84.99 -0.85% BTC 64,683.65 -0.95%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,883 +0.78% BTC $64,684 −0.95% VIX 22.91 +18.70% latest tape · as of 06:11 UTC
The Screen · Basic Materials

Croda International

CRDA.L · LSE · GBp · Market cap $4.0B

PASS · Titan Ethical · score 85.4
3,762.00 GBp

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 06:11 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price3,762.00 GBp at the 13 Nov 2026 close
  • Fair value1,881.00. Our model only; no analyst estimate to cross-check.
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readAccumulation, as of 15 Nov 2026
  • Ethical screenPasses, score 85.4 out of 100
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

FAIR-VALUE RANGE

Our fair-value range: range not available, base estimate 1,881.00 GBp (screen dated 2026-11-13).

Current read
Accumulation ?
Overvalued · screened 2026-11-13
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical passes the values gate
Price3,762.00 GBp
Fair value1,881.00Our model only; no analyst estimate to cross-check.
Ethical score85.4/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-11Read Accumulation3,209.00+17.2% to today ✓Markdown gives way to Accumulation first Accumulation read since July
2026-10-02Read Markdown3,209.00+17.2% to today Markup gives way to Markdown after a 12% rise in 5 weeks
2026-08-25Read Markup2,865.00+31.3% to today ✓Accumulation gives way to Markup
2026-07-02Read Accumulation2,865.00+31.3% to today ✓First review on file: Accumulation

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

Croda International holds its Accumulation at $3,762.00. Consolidating, no directional conviction, held for 43 days.

As held on the ledger · 2026-11-13
PhaseAccumulation
Quantitative stateConsolidating, no directional conviction, held for 43 days
Price at the screen$3,762.00
Valuation7,293.18 trailing · 1,793.10 forward price to earnings
Values screenPASS · score 85.4
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 20.42% Below 33% Interest-bearing debt is just 20.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 5.07% Below 33% Cash held in interest-bearing accounts and securities is 5.1% of assets, under the one-third limit. Pass
Receivables 8.66% Below 49% Money owed to the company is 8.7% of assets, under the 49% limit. Pass
Revenue purity 1.12% Below 5% Only 1.1% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Croda International clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 20%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when CRDA.L's ethical verdict changes

Today CRDA.L passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our model only; no analyst estimate to cross-check.

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our 1,881.00 GBp fair value estimate, 3.90% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

1,881.00Conservative1,881.00Base case1,881.00Growth case 3,762.00Price

Fair value range in GBp, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 100.0% above the base estimate.

Projections

Where our models see it going: fair-value estimate 1,881.00 GBp, range not available, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 1,793.1x forward earnings, the price already runs ahead of the business. It trades 100% above our 1,881.00 GBp fair value, so you would be buying at a premium, not a discount.

The fundamentals · plain-English read
Forward P/E1,793.1xexpensive even after accounting for its growth
Trailing P/E7,293.2xexpensive: the price assumes strong growth ahead
EPS, trailing0.44
EPS, forward1.79
Revenue growth+3.9%slow but positive growth
Profit margin0.0%currently unprofitable
Return on equity2.9%a modest return on shareholder capital
FCF yield1.66%
Dividend yield3.71%
Debt to equity0.32minimal debt: a conservative balance sheet
Market cap$4.0B

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CRDA.L trades on LSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-16 Accumulation $3,762.00 +4.1% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (14 analysts) rates it buy, with a mean price target of $3580.

2026-11-05 Accumulation $3,613.00 +2.0% Entry 9

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (14 analysts) rates it buy, with a mean price target of $3580.

2026-10-25 Accumulation $3,543.00 +10.4% Entry 8

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (14 analysts) rates it buy, with a mean price target of $3580.

2026-10-11 Accumulation · changed $3,209.00 +0.0% Entry 7

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (14 analysts) rates it buy, with a mean price target of $3580.

2026-10-02 Markdown · changed $3,209.00 +12.0% Entry 6

The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 12.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (14 analysts) rates it buy, with a mean price target of $3580.

2026-08-25 Markup · changed $2,865.00 +0.0% Entry 5

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (14 analysts) rates it buy, with a mean price target of $3580.

2026-07-25 Accumulation $2,865.00 +0.0% Entry 4

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (14 analysts) rates it buy, with a mean price target of $3580.

2026-07-18 Accumulation $2,865.00 +0.0% Entry 3

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 4%. Our forward projection puts the odds of a 10% gain over the next month near 10%. The street (14 analysts) rates it buy, with a mean price target of $3580.

2026-07-03 Accumulation $2,865.00 +0.0% Entry 2

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Accumulation $2,865.00 Entry 1

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · CRDA.L
DateInsiderTitleTypeSharesValue
2026-05-15 Breene (Sandra Elaine) 442 $16,215
2026-05-11 Breene (Sandra Elaine) 5 $193
2026-05-11 Breene (Sandra Elaine) 5 ·
2026-05-11 Fitzpatrick (Anthony Damien) 5 $193
2026-05-11 Fitzpatrick (Anthony Damien) 5 ·
2026-05-11 Brophy (Thomas Michael) 6 $232
2026-05-11 Brophy (Thomas Michael) 6 ·
2026-05-11 Lydon (Michelle Angela) 6 $232
2026-05-11 Lydon (Michelle Angela) 6 ·
2026-05-11 Foots (Stephen Edward) 5 $193

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $2,822.00 +7.7% · $1,077 +7.7%
2 months $2,967.00 +2.4% · $1,024 +2.4%
3 months $2,741.42 +10.8% $63.00 $1,131 +13.1%
6 months $2,718.43 +11.8% $63.00 $1,141 +14.1%
1 year $3,150.74 -3.6% $111.00 $999 -0.1%
2 years $4,228.80 -28.2% $221.00 $771 -22.9%
3 years $5,268.90 -42.3% $330.00 $639 -36.1%
5 years $7,035.21 -56.8% $538.00 $508 -49.2%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CRDA.L does next, these words stay.

Croda International · CRDA.L · Accumulation · $3,762.00
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.